Hematocrit control and thrombotic risk in patients with polycythemia vera treated with ruxolitinib in clinical practice.
Chojecki A, Boselli D, Dortilus A, Hamadeh I, Begley S, Chen T, Bose R, Podoltsev N, Zeidan AM, Balmaceda NB, Yacoub A, Ai J, Knight TG, Ragon BK, Shah NA, Sanikommu SR, Symanowski J, Mesa R, Grunwald MR.
Chojecki A, et al. Among authors: shah na.
Ann Hematol. 2024 Apr 25. doi: 10.1007/s00277-024-05735-7. Online ahead of print.
Ann Hematol. 2024.
PMID: 38662203